The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy; Use as a Single Agent in Susceptible Patients; Techniques Used to Identify Susceptible Patients

Sydney Shall, Terry Gaymes, Farzin Farzaneh, Nicola Curtin, Ghulam J Mufti

    Research output: Contribution to journal › Article › peer-review

    2 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy; Use as a Single Agent in Susceptible Patients; Techniques Used to Identify Susceptible Patients'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science